Status:
COMPLETED
rTMS Treatment in Patients With General Anxiety Disorder
Lead Sponsor:
Queen's University
Collaborating Sponsors:
Military Medical Academy, Bulgaria
Conditions:
Generalized Anxiety Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This study will compare the change detected by a standardized rating scale (Hamilton Anxiety Rating Scale) scores in the active treatment group as compared to sham (placebo) group after 6 weeks of rTM...
Eligibility Criteria
Inclusion
- signed patient informed consent;
- primary GAD diagnosis;
- HARS \>=15;
- male/female 18-65 years;
- without GAD pharmacotherapy at least last 2 weeks or if they are taking GAD medication it must be stable for at least 6 weeks prior to the start of the study and not be changed during the 6 weeks of the study treatment phase.
- Individual or group supportive psychotherapy may continue during the study but will not be allowed to start new psychotherapy during the 6 weeks of the study treatment phase.
Exclusion
- current serious Axis I schizophrenia, bipolar I, MDD;
- other primary Axis I in the opinion of investigator;
- HDRS \>=18;
- metallic implant in cranium except mouth;
- severe/unstable medical conditions;
- ect within last 3 months;
- history epilepsy;
- neurological disorder leading to increased intracranial pressure;
- severe cardiac disorder/intracardiac lines/pacemakers;
- current suicide risk.
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2012
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00616447
Start Date
January 1 2008
End Date
November 1 2012
Last Update
December 16 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Military Medical Academy
Sofia, Bulgaria
2
Providence Care Mental Health Services
Kingston, Ontario, Canada, K7L4X3